발행물
컨퍼런스
2021 International Congress of Diabetes and Metabolism and the 13th AASD Scientific Meeting
2021
,
Empagliflozin versus dapagliflozin for type 2 diabetes in combination with metformin, dipeptidyl peptidase 4 inhibitor and sulfonylurea: 3-year prospective observational study
The virtual 57th EASD Annual Meeting
Empagliflozin versus dapagliflozin for type 2 diabetes in combination with metformin, dipeptidyl peptidase-4 inhibitor and sulfonylurea: 3-year prospective study
The 17the Asia-Oceania Congress of Endocrinology and The seoul International Congress of Endocrinology and Metabolism
2020
Prevalence of Genetic Variants Associated with Maturity-Onset Diabetes of The Young (MODY) in Korean Patients with Early Onset Diabetes Mellitus
Achievement of Low Density Lipoprotein Cholesterol (LDL-C) Targets in Patients with Type 2 Diabetes in Real-World Evidence from Korea: Comparison with Recent Guidelines for Management of Dyslipidemia
The 21st international Vascular Biology Meeting
Association of Serum Omentin-1 and Visfatin Levels With Coronary Artery Disease in Patients With Type 2 Diabetes Mellitus